C0030298||human pancreatic polypeptide
C0231353||reduces food intake
C0025929||mice
C0030298||Human pancreatic polypeptide
C0030298||Human pancreatic polypeptide
C0858274||suppress appetite
C0013470||food intake
C0028754||obesity
C0025517||metabolic disorders
C0030298||Human pancreatic polypeptide
C0032483||polyethylene glycols
C0032483||polyethylene glycols
C0243095||target activity
C1518961||solution-phase peptide synthesis
C0014597||human epithelial cells
C0227349||human colonic mucosa
C0040669||receptor-transfected
C0007600||artificial cell lines
C0304926||Human blood plasma
C0023884||porcine liver
C1521751||C57BL/6JRj mice
C0086311||fasting-induced food intake
C0014609||human epithelia
C0227349||colonic mucosal
C0030298||Human pancreatic polypeptide
C0030956||peptides
C0030956||peptides
C0032483||PEG size
C0030956||Peptides
C0032483||22 kDa PEG
C0032483||PEG22
C0304926||blood plasma
C1439852||incubation
C0023884||liver homogenates
C0030298||hPP2-36
C0030298||hPP2-36
C0030298||Human pancreatic polypeptide
C0013470||food intake
C0025929||mice
C0032483||PEG22
C0030298||Human pancreatic polypeptide
C2267218||biological activities
C0872152||drug development